NBP insider transactions
NovaBridge Biosciences (NBP) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for NBP
- SEC Form 4 filed by Chief Commercial Officer Hagler Mark Arnold4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 4 filed by General Counsel Lin Liwei Lorraine4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Gupta Srishti4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Gupta Srishti3 - NovaBridge Biosciences (0001778016) (Issuer)
- SVP, Clinical Development Xu Cong Claire converted options into 12,432 units of Ordinary Shares and sold $3,992 worth of Ordinary Shares (4,485 units at $0.89), increasing direct ownership by 3% to 298,101 units (SEC Form 4)4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 4 filed by Director Fu Wei4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 4 filed by Chief Bus. Development Officer Cao Sean Wuxiong4 - NovaBridge Biosciences (0001778016) (Issuer)
- Chief Medical Officer Dennis Phillip Andrew converted options into 23,695 units of Ordinary Shares and sold $5,606 worth of Ordinary Shares (8,494 units at $0.66), increasing direct ownership by 11% to 157,941 units (SEC Form 4)4 - NovaBridge Biosciences (0001778016) (Issuer)
- SVP, Clinical Development Xu Cong Claire converted options into 9,382 units of Ordinary Shares and sold $13,766 worth of Ordinary Shares (3,494 units at $3.94), increasing direct ownership by 2% to 290,154 units (SEC Form 4)4 - NovaBridge Biosciences (0001778016) (Issuer)
- Officer Cao Sean Wuxiong sold $42,584 worth of Ordinary Shares (21,399 units at $1.99), decreasing direct ownership by 38% to 35,073 units (SEC Form 4) to cover taxes4 - NovaBridge Biosciences (0001778016) (Issuer)
- Officer Hagler Mark Arnold bought $577,300 worth of Ordinary Shares (230,000 units at $2.51) (SEC Form 4)4 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Hagler Mark Arnold3 - NovaBridge Biosciences (0001778016) (Issuer)
- Amendment: SEC Form 3 filed by new insider Xu Cong Claire3/A - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Yang Conor Chia-Hung3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Chu Denny Hsueh Wen3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Dennis Phillip Andrew3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Lin Liwei Lorraine3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Fu Xi-Yong3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Zhang Xiaofan Neo3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Lei Ming Kyler3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Wu Joanna Xuqiong3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Fu Wei3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Cao Sean Wuxiong3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Cunningham Emmett3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Xu Cong Claire3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Liu Xin3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Zhang Adeline Yi3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Woo Ian Ying3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Lenz Robert A.3 - NovaBridge Biosciences (0001778016) (Issuer)
- SEC Form 3 filed by new insider Au Chun Kwok Alan3 - NovaBridge Biosciences (0001778016) (Issuer)